ברקלוד 1 מ"ג

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

ENTECAVIR 1 MG

Доступно од:

BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED

АТЦ код:

J05AF10

Фармацеутски облик:

FILM COATED TABLETS

Пут администрације:

PER OS

Произведен од:

BRISTOL MYERS SQUIBB SPA, ITALY

Терапеутска група:

ENTECAVIR

Терапеутске индикације:

Baraclude is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. This indication is based on clinical trial data in patients with HBeAg positive and HBeAg negative HBV infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis B.Decompensated liver disease.

Датум одобрења:

2009-02-01